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Summary. Cyclophosphamide (CP), an antineoplastic 
and immunosuppresive agent, even when administered 
in large doses, slightly affects the quantity of blood 
platelets. The aim of the present study was to analyse the 
effect of single intraperitoneal administration of CP 
(150mg/kg b.w.) on the quantitative changes in platelets 
obtained from the left and right ventricle of the heart, as 
well as to evaluate the occurrence of megakaryocytes in 
lung tissue depending on the period of time that passed 
from CP administration. 
In control subgroups, fewer platelets were found in 
the blood collected from the RV compared with the left 
ventricle at all time intervals. After 1 and 3 days 
following i.p, administration of CP, a decrease was 
observed in the number of platelets both in the blood 
from the right ventricle and left ventricle when 
compared with control. However, after 14 days, the 
number of platelets in the blood from the left ventricle 
was higher, compared with the left ventricle and right 
ventricle of control animals, and significantly higher 
(p<0.001747), compared with their number obtained 
from the right ventricle of CP-receiving animals. 
Simultaneous ultrastructural examinations with 
transmission electron microscopy revealed the increased 
number of platelets in the lung vascular bed of CP- 
receiving rats at all time intervals. However, megakaryo- 
cytes were found 7 and 14 days after administration of 
CP. The findings clearly indicate that the lungs could be 
a major place of thrombopoiesis following therapy with 
a single large dose of CP. 
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Introduction 
The theory of Wright, of 1910, ascribing platelet 
production to the bone marrow has been generally 
accepted. Platelets are produced via fragmentation of the 
cytoplasm of megakaryocytes. Megakaryocytes occur in 
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the vicinity of vascular sinuses of the marrow and 
produce two types of cytoplasmic processes (Tavassoli 
and Aoki, 1989; Young, 1989). One type, derived from 
the external layer of megakaryocyte cytoplasm, is devoid 
of cellular organelles. The other type, rich in cyto- 
plasmic organelles and containing alpha granules, is a 
source of platelets.  Already in 1914,  Oelhaffen 
investigated the presence of megakaryocytes in 
peripheral venous blood. Later studies revealed that 
megakaryocytes pass with blood from the marrow to a 
number of organs, particularly to the lungs (Trowbridge, 
1988, 1990). They can be found in the capillaries of the 
liver, spleen, kidneys and heart and sporadically in 
septum and pathological exudative fluids from the 
pleural and peritonea1 cavities (Aabo and Hansen, 1978; 
Koss, 1979; Kumar and Naylor, 1980). 
The presence of megakaryocytes in capillary vessels 
of the human lungs was first found by Aschoff (1893). 
The studies by other authors reveal that the occurrence 
of megakaryocytes in the vascular bed of the lungs and 
in the peripheral blood is a physiological phenomenon 
(Levine et al., 1990,  1993) which can become 
considerably intensified in certain pathological 
conditions (Hume et al., 1964; Aabo and Hansen, 1978). 
A large increase in the number of megakaryocytes in the 
lungs is observed in those who die of disseminated intra- 
vascular clotting (DIC), acute infections, haemorrhages, 
certain types of neoplasms, liver failure and shock (Aabo 
and Hansen, 1978). Breslow et al. (1968) found a 
considerable increase in the number of megakaryocytes 
and platelets in the peripheral venous blood in post- 
operative patients. 
The aim of the present study was to analyse the 
effect of a single large dose of cyclophosphamide (CP), 
an antineoplastic and immunosuppresive agent, on the 
change in the number of platelets in arterial and venous 
blood and to evaluate the occurrence of megakaryocytes 
in lung tissue according to the time that elapsed from CP 
administration. 
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